Gagnon Robert E.
- SEC CIK
- 0001504983
In the past year, 4 open-market sale filings worth $193.4K and no purchases.
Current role at each company
- IRD Opus Genetics, Inc.Chief Financial Officeras of Sep 8, 2026
- HBIO Harvard Bioscience IncDirectoras of Jun 11, 2026
- VSTM Verastem, Inc.Directoras of Dec 18, 2025
- BBLG Bone Biologics CorpDirectoras of Jun 6, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $193.4K
- 4 filings
- Net
- −$193.4K
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Gagnon Robert E. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IRD Opus Genetics, Inc.
Chief Financial Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 27, 2026 (view filing) | Apr 23 | 4 days | Gagnon Robert E.Chief Financial Officer | SSale | −7.84K | $5.18 | −$40.6K | −1.3%592.2K after | |
| Jul 27, 2026 (view filing)4:06 PM ET | Jul 23 | 4 days | Gagnon Robert E.Chief Financial Officer | SSale | −7.78K | $2.95 | −$22.9K | −1.3%584.4K after | |
| Sep 8, 2026 (view filing)4:05 PM ET | Sep 3 | 5 days | Gagnon Robert E.Chief Financial Officer | SSale | −28.0K | $4.54 | −$127.2K | −4.8%556.4K after |
VSTM Verastem, Inc.
Director22 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 22, 2021 (view filing) | Dec 20 | 2 days | Gagnon Robert E.Chief Financial Officer | SSale | −5.50K | $2.27 | −$12.5K | −0.9%578.9K after | |
| Jan 5, 2022 (view filing) | Jan 3 | 2 days | Gagnon Robert E.Chief Financial Officer | SSale | −19.6K | $2.05 | −$40.2K | −3.4%559.3K after | |
| Mar 23, 2022 (view filing) | Mar 21 | 2 days | Gagnon Robert E.Chief Financial Officer | SSale | −1.41K | $1.27 | −$1.79K | −0.3%557.9K after | |
| May 17, 2022 (view filing) | May 16 | 1 day | Gagnon Robert E.Chief Financial Officer | SSale | −16.6K | $1.03 | −$17.1K | −2.7%591.3K after | |
| Jun 22, 2022 (view filing) | Jun 21 | 1 day | Gagnon Robert E.Chief Financial Officer | SSale | −1.35K | $1.14 | −$1.54K | −0.2%589.9K after | |
| Sep 21, 2022 (view filing) | Sep 19 | 2 days | Gagnon Robert E.Chief Financial Officer | SSale | −1.35K | $1.13 | −$1.52K | −0.2%588.6K after | |
| Dec 20, 2022 (view filing)4:09 PM ET | Dec 16-19 | 4 days | Gagnon Robert E.Director | SSale | −13.8K | $0.3969 | −$5.49K | −2.4%574.7K after | 2 lots |
| Mar 20, 2023 (view filing)4:59 PM ET | Mar 16-20 | 4 days | Gagnon Robert E.Director | SSale | −5.32K | $0.4094 | −$2.18K | −0.9%569.4K after | 2 lots |
| Jun 21, 2023 (view filing) | Jun 16-20 | 5 days | Gagnon Robert E.Director | SSale | −413 | $10.04 | −$4.15K | −0.9%47.0K after | 2 lots |
| Sep 20, 2023 (view filing) | Sep 18-19 | 2 days | Gagnon Robert E.Director | SSale | −408 | $9.89 | −$4.03K | −0.9%46.6K after | 2 lots |